Voyager Therapeutics (VYGR) Short-term Investments (2015 - 2026)

Voyager Therapeutics has disclosed Short-term Investments across 12 years of filings, most recently posting $98.2 million for Q1 2026.

• Short-term Investments for Q1 2026 came in at $98.2 million, down 39.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $98.2 million (down 39.13% YoY), and the FY2025 annual result was $131.1 million, down 32.85% from the prior year.
• Short-term Investments came in at $98.2 million for Q1 2026 at Voyager Therapeutics, down from $131.1 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $294.9 million in Q2 2024 to a low of $5.0 million in Q1 2023.
• The 5-year median for Short-term Investments is $161.3 million (2025), against an average of $132.2 million.
• Across the five-year window, Short-term Investments slumped 85.72% in 2023 and soared 5036.99% in 2024, its largest moves.
• Voyager Therapeutics' Short-term Investments stood at $19.9 million in 2022, then soared by 714.89% to $162.1 million in 2023, then increased by 20.51% to $195.3 million in 2024, then sank by 32.85% to $131.1 million in 2025, then slipped by 25.15% to $98.2 million in 2026.
• The last three Short-term Investments figures came in at $98.2 million (Q1 2026), $131.1 million (Q4 2025), and $163.8 million (Q3 2025), per Business Quant data.